(NYSE: COR) Cencora's forecast annual revenue growth rate of 5.12% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 6.72%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.83%.
Cencora's revenue in 2025 is $316,654,371,000.On average, 5 Wall Street analysts forecast COR's revenue for 2025 to be $62,193,639,526,864, with the lowest COR revenue forecast at $62,100,015,898,129, and the highest COR revenue forecast at $62,254,400,854,769. On average, 6 Wall Street analysts forecast COR's revenue for 2026 to be $66,613,574,008,763, with the lowest COR revenue forecast at $65,932,535,686,373, and the highest COR revenue forecast at $67,675,364,448,580.
In 2027, COR is forecast to generate $71,367,888,702,634 in revenue, with the lowest revenue forecast at $70,012,773,243,170 and the highest revenue forecast at $72,602,098,231,826.